Cargando…
Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism
Biomarkers unrelated to myocardial necrosis, such as cystatin C, copeptin, and mid-regional pro-adrenomedullin (MR-proADM), showed promise for cardiovascular risk prediction. Knowing whether they are comparable to cardiac biomarkers such as high-sensitive cardiac-troponin T (hs-cTnT) or N-terminal p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878757/ https://www.ncbi.nlm.nih.gov/pubmed/27219621 http://dx.doi.org/10.1371/journal.pone.0155973 |
_version_ | 1782433604612128768 |
---|---|
author | Vuilleumier, Nicolas Simona, Aurélien Méan, Marie Limacher, Andreas Lescuyer, Pierre Gerstel, Eric Bounameaux, Henri Aujesky, Drahomir Righini, Marc |
author_facet | Vuilleumier, Nicolas Simona, Aurélien Méan, Marie Limacher, Andreas Lescuyer, Pierre Gerstel, Eric Bounameaux, Henri Aujesky, Drahomir Righini, Marc |
author_sort | Vuilleumier, Nicolas |
collection | PubMed |
description | Biomarkers unrelated to myocardial necrosis, such as cystatin C, copeptin, and mid-regional pro-adrenomedullin (MR-proADM), showed promise for cardiovascular risk prediction. Knowing whether they are comparable to cardiac biomarkers such as high-sensitive cardiac-troponin T (hs-cTnT) or N-terminal pro-Brain natriuretic peptide (NT-proBNP) in elderly patients with acute non-massive pulmonary embolism (NMPE) remains elusive. This study aims at comparing the prognostic accuracy of cardiac and non-cardiac biomarkers in patients with NMPE aged ≥65 years over time. In the context of the SWITCO65+ cohort, we evaluated 227 elderly patients with an available blood sample taken within one day from diagnosis. The primary study endpoint was defined as PE-related mortality and the secondary endpoint as PE-related complications. The biomarkers’ predictive ability at 1, 3, 12 and 24 months was determined using C-statistics and Cox regression. For both study endpoints, C-statistics (95% confidence interval) were stable over time for all biomarkers, with the highest value for hs-cTnT, ranging between 0.84 (0.68–1.00) and 0.80 (0.70–0.90) for the primary endpoint, and between 0.74 (0.63–0.86) and 0.65 (0.57–0.73) for the secondary endpoint. For both study endpoints, cardiac biomarkers were found to be independently associated with risk, NT-proBNP displaying a negative predictive value of 100%. Among non-cardiac biomarkers, only copeptin and MR-proADM were independent predictors of PE-related mortality but they were not independent predictors of PE-related complications, and displayed lower negative predictive values. In elderly NMPE patients, cardiac biomarkers appear to be valuable prognostic to identify very low-risk individuals. Trial Registration: ClinicalTrials.gov NCT00973596 |
format | Online Article Text |
id | pubmed-4878757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48787572016-06-09 Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism Vuilleumier, Nicolas Simona, Aurélien Méan, Marie Limacher, Andreas Lescuyer, Pierre Gerstel, Eric Bounameaux, Henri Aujesky, Drahomir Righini, Marc PLoS One Research Article Biomarkers unrelated to myocardial necrosis, such as cystatin C, copeptin, and mid-regional pro-adrenomedullin (MR-proADM), showed promise for cardiovascular risk prediction. Knowing whether they are comparable to cardiac biomarkers such as high-sensitive cardiac-troponin T (hs-cTnT) or N-terminal pro-Brain natriuretic peptide (NT-proBNP) in elderly patients with acute non-massive pulmonary embolism (NMPE) remains elusive. This study aims at comparing the prognostic accuracy of cardiac and non-cardiac biomarkers in patients with NMPE aged ≥65 years over time. In the context of the SWITCO65+ cohort, we evaluated 227 elderly patients with an available blood sample taken within one day from diagnosis. The primary study endpoint was defined as PE-related mortality and the secondary endpoint as PE-related complications. The biomarkers’ predictive ability at 1, 3, 12 and 24 months was determined using C-statistics and Cox regression. For both study endpoints, C-statistics (95% confidence interval) were stable over time for all biomarkers, with the highest value for hs-cTnT, ranging between 0.84 (0.68–1.00) and 0.80 (0.70–0.90) for the primary endpoint, and between 0.74 (0.63–0.86) and 0.65 (0.57–0.73) for the secondary endpoint. For both study endpoints, cardiac biomarkers were found to be independently associated with risk, NT-proBNP displaying a negative predictive value of 100%. Among non-cardiac biomarkers, only copeptin and MR-proADM were independent predictors of PE-related mortality but they were not independent predictors of PE-related complications, and displayed lower negative predictive values. In elderly NMPE patients, cardiac biomarkers appear to be valuable prognostic to identify very low-risk individuals. Trial Registration: ClinicalTrials.gov NCT00973596 Public Library of Science 2016-05-24 /pmc/articles/PMC4878757/ /pubmed/27219621 http://dx.doi.org/10.1371/journal.pone.0155973 Text en © 2016 Vuilleumier et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vuilleumier, Nicolas Simona, Aurélien Méan, Marie Limacher, Andreas Lescuyer, Pierre Gerstel, Eric Bounameaux, Henri Aujesky, Drahomir Righini, Marc Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism |
title | Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism |
title_full | Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism |
title_fullStr | Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism |
title_full_unstemmed | Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism |
title_short | Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism |
title_sort | comparison of cardiac and non-cardiac biomarkers for risk stratification in elderly patients with non-massive pulmonary embolism |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878757/ https://www.ncbi.nlm.nih.gov/pubmed/27219621 http://dx.doi.org/10.1371/journal.pone.0155973 |
work_keys_str_mv | AT vuilleumiernicolas comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT simonaaurelien comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT meanmarie comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT limacherandreas comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT lescuyerpierre comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT gersteleric comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT bounameauxhenri comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT aujeskydrahomir comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism AT righinimarc comparisonofcardiacandnoncardiacbiomarkersforriskstratificationinelderlypatientswithnonmassivepulmonaryembolism |